Gastric Cancer Drug Market Report

Global and Region Gastric Cancer Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：225
  • REPORT CODE：GMM891695
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastric Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastric Cancer Drugmarket, defines the market attractiveness level of Gastric Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastric Cancer Drug industry, describes the types of Gastric Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastric Cancer Drug market and the development prospects and opportunities of Gastric Cancer Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastric Cancer Drug market in Chapter 13.

    By Player:

    • Boehringer Ingelheim

    • Eddingpharm

    • Eli-lilly

    • Bristol-Myers Squibb

    • AROG Pharmaceuticals

    • Roche

    • ARIAD Pharmaceuticals

    • Otsuka Holdings

    • Merck

    • Novartis

    • Five Prime

    • Ipsen Biopharmaceuticals

    • Eli Lilly

    • Amgen

    • Hoffmann-La Roche

    • Bayer HealthCare

    • BIND Therapeutics

    • Boston Biomedical

    • AB Science

    • Sanofi

    By Type:

    • Oral

    • Injectable

    By End-User:

    • Hospitals

    • Homecare

    • Specialty Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastric Cancer Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastric Cancer Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastric Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastric Cancer Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastric Cancer Drug Market Analysis and Outlook to 2022

    • 7.1 Global Gastric Cancer Drug Consumption (2017-2022)

    • 7.2 United States Gastric Cancer Drug Consumption (2017-2022)

    • 7.3 Europe Gastric Cancer Drug Consumption (2017-2022)

    • 7.4 China Gastric Cancer Drug Consumption (2017-2022)

    • 7.5 Japan Gastric Cancer Drug Consumption (2017-2022)

    • 7.6 India Gastric Cancer Drug Consumption (2017-2022)

    • 7.7 South Korea Gastric Cancer Drug Consumption (2017-2022)

    8 Region and Country-wise Gastric Cancer Drug Market Analysis and Outlook to 2028

    • 8.1 Global Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.2 United States Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.4 China Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.6 India Gastric Cancer Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastric Cancer Drug Consumption Forecast (2022-2028)

    9 Global Gastric Cancer Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastric Cancer Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injectable Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastric Cancer Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastric Cancer Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastric Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Injectable Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastric Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastric Cancer Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastric Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastric Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastric Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastric Cancer Drug Market Competitive Analysis

    • 14.1 Boehringer Ingelheim

      • 14.1.1 Boehringer Ingelheim Company Details

      • 14.1.2 Boehringer Ingelheim Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Boehringer Ingelheim Gastric Cancer Drug Product and Service

    • 14.2 Eddingpharm

      • 14.2.1 Eddingpharm Company Details

      • 14.2.2 Eddingpharm Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eddingpharm Gastric Cancer Drug Product and Service

    • 14.3 Eli-lilly

      • 14.3.1 Eli-lilly Company Details

      • 14.3.2 Eli-lilly Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli-lilly Gastric Cancer Drug Product and Service

    • 14.4 Bristol-Myers Squibb

      • 14.4.1 Bristol-Myers Squibb Company Details

      • 14.4.2 Bristol-Myers Squibb Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bristol-Myers Squibb Gastric Cancer Drug Product and Service

    • 14.5 AROG Pharmaceuticals

      • 14.5.1 AROG Pharmaceuticals Company Details

      • 14.5.2 AROG Pharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AROG Pharmaceuticals Gastric Cancer Drug Product and Service

    • 14.6 Roche

      • 14.6.1 Roche Company Details

      • 14.6.2 Roche Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Gastric Cancer Drug Product and Service

    • 14.7 ARIAD Pharmaceuticals

      • 14.7.1 ARIAD Pharmaceuticals Company Details

      • 14.7.2 ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ARIAD Pharmaceuticals Gastric Cancer Drug Product and Service

    • 14.8 Otsuka Holdings

      • 14.8.1 Otsuka Holdings Company Details

      • 14.8.2 Otsuka Holdings Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Otsuka Holdings Gastric Cancer Drug Product and Service

    • 14.9 Merck

      • 14.9.1 Merck Company Details

      • 14.9.2 Merck Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck Gastric Cancer Drug Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Gastric Cancer Drug Product and Service

    • 14.11 Five Prime

      • 14.11.1 Five Prime Company Details

      • 14.11.2 Five Prime Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Five Prime Gastric Cancer Drug Product and Service

    • 14.12 Ipsen Biopharmaceuticals

      • 14.12.1 Ipsen Biopharmaceuticals Company Details

      • 14.12.2 Ipsen Biopharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Ipsen Biopharmaceuticals Gastric Cancer Drug Product and Service

    • 14.13 Eli Lilly

      • 14.13.1 Eli Lilly Company Details

      • 14.13.2 Eli Lilly Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Eli Lilly Gastric Cancer Drug Product and Service

    • 14.14 Amgen

      • 14.14.1 Amgen Company Details

      • 14.14.2 Amgen Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Amgen Gastric Cancer Drug Product and Service

    • 14.15 Hoffmann-La Roche

      • 14.15.1 Hoffmann-La Roche Company Details

      • 14.15.2 Hoffmann-La Roche Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Hoffmann-La Roche Gastric Cancer Drug Product and Service

    • 14.16 Bayer HealthCare

      • 14.16.1 Bayer HealthCare Company Details

      • 14.16.2 Bayer HealthCare Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Bayer HealthCare Gastric Cancer Drug Product and Service

    • 14.17 BIND Therapeutics

      • 14.17.1 BIND Therapeutics Company Details

      • 14.17.2 BIND Therapeutics Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 BIND Therapeutics Gastric Cancer Drug Product and Service

    • 14.18 Boston Biomedical

      • 14.18.1 Boston Biomedical Company Details

      • 14.18.2 Boston Biomedical Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Boston Biomedical Gastric Cancer Drug Product and Service

    • 14.19 AB Science

      • 14.19.1 AB Science Company Details

      • 14.19.2 AB Science Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 AB Science Gastric Cancer Drug Product and Service

    • 14.20 Sanofi

      • 14.20.1 Sanofi Company Details

      • 14.20.2 Sanofi Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Sanofi Gastric Cancer Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastric Cancer Drug

    • Figure Gastric Cancer Drug Picture

    • Table Global Gastric Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastric Cancer Drug Consumption by Country (2017-2022)

    • Figure United States Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure China Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure India Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastric Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Cancer Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastric Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injectable Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injectable Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastric Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastric Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Gastric Cancer Drug Product and Service

    • Table Eddingpharm (Foundation Year, Company Profile and etc.)

    • Table Eddingpharm Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eddingpharm Gastric Cancer Drug Product and Service

    • Table Eli-lilly (Foundation Year, Company Profile and etc.)

    • Table Eli-lilly Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli-lilly Gastric Cancer Drug Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Gastric Cancer Drug Product and Service

    • Table AROG Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table AROG Pharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AROG Pharmaceuticals Gastric Cancer Drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Gastric Cancer Drug Product and Service

    • Table ARIAD Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARIAD Pharmaceuticals Gastric Cancer Drug Product and Service

    • Table Otsuka Holdings (Foundation Year, Company Profile and etc.)

    • Table Otsuka Holdings Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Holdings Gastric Cancer Drug Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Gastric Cancer Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gastric Cancer Drug Product and Service

    • Table Five Prime (Foundation Year, Company Profile and etc.)

    • Table Five Prime Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Five Prime Gastric Cancer Drug Product and Service

    • Table Ipsen Biopharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ipsen Biopharmaceuticals Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen Biopharmaceuticals Gastric Cancer Drug Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Gastric Cancer Drug Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Gastric Cancer Drug Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Gastric Cancer Drug Product and Service

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Gastric Cancer Drug Product and Service

    • Table BIND Therapeutics (Foundation Year, Company Profile and etc.)

    • Table BIND Therapeutics Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIND Therapeutics Gastric Cancer Drug Product and Service

    • Table Boston Biomedical (Foundation Year, Company Profile and etc.)

    • Table Boston Biomedical Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Biomedical Gastric Cancer Drug Product and Service

    • Table AB Science (Foundation Year, Company Profile and etc.)

    • Table AB Science Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science Gastric Cancer Drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Gastric Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Gastric Cancer Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US